Colorectal Cancer: Genetic Underpinning and Molecular Therapeutics for Precision Medicine
Open Access
Abstract
Colorectal cancer (CRC) accounts for about 10% of all cancer cases and 9% of cancer-related deaths globally. In the United States alone, CRC represents approximately 12.6% of all cancer cases, with a mortality rate of about 8%. CRC is now the first leading cause of cancer death in men younger than age 50 and second in women younger than age 50. This review delves into the genetic landscape of CRC, highlighting key mutations and their implications in disease progression and treatment. We provide an overview of the current and emerging therapeutic strategies tailored to individual genomic profiles.Keywords
This publication has 82 references indexed in Scilit:
- European expert panel consensus on the clinical management of BRAF-mutant metastatic colorectal cancerCancer Treatment Reviews, 2023
- MO42-6 The clinical and molecular landscape of focal MET-amplified metastatic colorectal cancer patientsAnnals of Oncology, 2022
- Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease?Translational Oncology, 2021
- Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNATargeted Oncology, 2021
- Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancerClinical and Translational Oncology, 2019
- RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancerMolecular Oncology, 2019
- Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and IrinotecanJAMA Oncology, 2019
- The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenariosCancer Treatment Reviews, 2018
- Molecular Markers Predictive of Chemotherapy Response in Colorectal CancerCurrent Gastroenterology Reports, 2015
- TP53 mutation in colorectal cancerHuman Mutation, 2003